Citadel Advisors’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,000
Closed -$13.5K 14301
2025
Q4
$13.5K Buy
+11,000
New +$15.9K ﹤0.01% 12407
2025
Q1
Sell
-7,100
Closed -$8.24K 15631
2024
Q4
$8.24K Sell
7,100
-900
-11% -$1.14K ﹤0.01% 13690
2024
Q3
$9.36K Sell
8,000
-3,600
-31% -$4.5K ﹤0.01% 13262
2024
Q2
$14.6K Sell
11,600
-8,400
-42% -$14.4K ﹤0.01% 12870
2024
Q1
$37K Buy
+20,000
New +$29.5K ﹤0.01% 12477
2023
Q4
Sell
-198
Closed -$202 15314
2023
Q3
$202 Hold
198
﹤0.01% 14131
2023
Q2
$240 Buy
+198
New +$244 ﹤0.01% 14176
2023
Q1
Sell
-1,387
Closed -$1.18K 15566
2022
Q4
$1.18K Buy
+1,387
New +$2.26K ﹤0.01% 14517
2022
Q2
Sell
-8,633
Closed -$37K 14173
2022
Q1
$37K Sell
8,633
-3,267
-27% -$13.7K ﹤0.01% 12990
2021
Q4
$58K Sell
11,900
-167
-1% -$1.22K ﹤0.01% 13170
2021
Q3
$115K Sell
12,067
-17,000
-58% -$191K ﹤0.01% 12696
2021
Q2
$431K Buy
+29,067
New +$562K ﹤0.01% 10390
2018
Q3
Sell
-579
Closed -$23K 9713
2018
Q2
$23K Buy
+579
New +$25.2K ﹤0.01% 8616
2016
Q1
Sell
-67
Closed -$9K 8023
2015
Q4
$9K Sell
67
-16
-19% -$2.34K ﹤0.01% 8311
2015
Q3
$12K Sell
83
-630
-88% -$175K ﹤0.01% 8409
2015
Q2
$233K Buy
713
+471
+195% +$151K ﹤0.01% 6118
2015
Q1
$74K Buy
+242
New +$67.3K ﹤0.01% 7106

Other funds holding VANI

Citadel Advisors's VANI Position: Q1 2026 in Review

Citadel Advisors sold out of Vivani Medical (VANI) in Q1 2026, closing a stake of 40,409 shares — an estimated $50.5K sold.

Citadel Advisors first reported a position in VANI in Q1 2015 and held it in 19 quarters. The position peaked at $440K in Q2 2021. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.

  • Citadel Advisors reported no remaining Vivani Medical position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 40,409 Vivani Medical shares in Q1 2026, an estimated $50.5K.
  • Citadel Advisors first reported a position in Vivani Medical in Q1 2015 and held it in 19 quarters.
  • Citadel Advisors's Vivani Medical position peaked at $440K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.